Navigation Links
Sinovac Holds 2012 Annual General Meeting of Shareholders
Date:8/23/2012

BEIJING, Aug. 23, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2012 Annual General Meeting of Shareholders on Wednesday, August 22, 2012 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted by proxy. The meeting was held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua.

During the meeting, the four proposals that required the affirmative vote of a majority of the shares cast were approved as follows: all of the directors were re-elected; the audited consolidated financial statements for financial year ended December 31, 2011 were approved, the selection of Ernst & Young as independent auditor was confirmed, and the 2012 Share Incentive Plan was approved. Proposal No. 5 relating to amending Sections 7.5 of the Company's by-laws, which requires the affirmative vote of a majority of common shares outstanding, was not approved.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu) and H1N1 influenza (swine flu), as well as animal rabies vaccine for canines.  In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program.  The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program.  Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
2. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
3. Sinovac Schedules 2012 Annual Meeting of Shareholders
4. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
5. Sinovac Reports Unaudited First Quarter 2012 Financial Results
6. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
7. Mike Golic, ESPN Radio Personality and Former Philadelphia Eagle, Holds Pre-Season "Training Camp" for People With Type 2 Diabetes
8. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
9. Ari Fleischer and Howard Dean to Debate at Beckers 19th Annual Ambulatory Surgery Centers Conference
10. Ultra Clean to Present at the ThinkEquity 9th Annual Growth Conference
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... DUBLIN , July 25, 2014 ... the "Global Ophthalmic Diagnostic Devices Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 About Ophthalmic Diagnostic Device ... device used to identify a defect or deficiency in ... patients with ophthalmic disorders such as presbyopia, cataracts, glaucoma, ...
(Date:7/25/2014)... BERWYN, Pa. , July 25, 2014  AMETEK, ... appointment of Kurtis L. Goos as Vice ... Engineered Materials, Interconnects and Packaging (EMIP) Division. ... has extensive general management and business development experience, especially ... to make important contributions to the continued growth and ...
(Date:7/25/2014)... Leading events organizer UBM Live announces that CPhI ... São Paulo, Brazil from 5 th ... co-locate with Food Ingredients South America (FiSA), creating ... pharmaceutical industry.      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) Three ... exploring the South America market as ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4
... SCHWARTZ LED TEAM, Article in Modern,Pathology set for print ... GENE,S ACTIVATION IN MAJORITY OF BREAST,CANCER CASES, WASHINGTON, ... 70% of prostate cancer tumors, the same gene that ... cases, report,scientists at the George Washington University Medical Center ...
... Novexel, a speciality pharmaceutical,company focused on the ... the significant global problem of microbial,resistance, announces that ... posters,at the joint annual meeting of the Interscience ... Disease Society of America (48th,annual ICAAC/IDSA 46th annual ...
Cached Medicine Technology:Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report 2Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting 2
(Date:7/27/2014)... (PRWEB) July 27, 2014 Ticket Down ... at The Forum in Inglewood, California on November 15th. ... diehard fans can expect to hear songs from this amazing album ... Summer concert in Inglewood, California at The Forum will be released ... at 10:00 a.m. today local time TicketDown.com. This popular secondary ...
(Date:7/27/2014)... According to a new market report published ... Operative Devices, and Visualization Systems) - Global Industry Analysis, ... endoscopy devices market was valued at USD 24.9 billion ... CAGR of 6.8% from 2013 to 2019, to reach ... , Endoscopy procedures are performed by inserting rod shaped ...
(Date:7/27/2014)... Scientists from The University of Manchester have discovered why medication ... findings, published in Nature Medicine , show that drugs ... clock. , In the UK pneumonia, which is ... each year and is more serious for babies, young children, ... , More than 5 million people in the UK ...
(Date:7/27/2014)... Prominent Vancouver Chiropractors, Dr. Shervin Ranjbar ... the hamstring release procedure in Vancouver, BC. Both these ... Vancouver and have years of experience in the field ... out by the two professionals using a foam roller ... to release tight hamstrings and relieve the client of ...
(Date:7/27/2014)... The North American security and surveillance ... million in 2014, and it is expected to reach ... The report incorporates the factors that influence a country’s ... rates and projected total expenditure. The report also throws ... Apart from the general overview of the companies, it ...
Breaking Medicine News(10 mins):Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Drugs used to treat lung disease work with the body clock 2Health News:Renowned Vancouver Chiropractors Demonstrates Hamstring Release in Vancouver, BC 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5
... proportions”, a study finding which says that hormone replacement therapy ... of heart disease. , The study published in ... replacement therapy or HRT, taken by women in their 50’s ... attacks and other such conditions. , This finding ...
... cancer patients in the U.S. fails to receive the ... study of hospital data from nine states found that ... Hispanic race, or insured by Medicaid, were at greatest ... oncologists, by surgeons who perform few ovarian cancer surgeries, ...
... land. But there too strident voices are being raised in ... to ensure availability of lower-cost copies of biotechnology drugs that ... year. ,Generics are now allowed only for traditional, ... for complex biological drugs such as hormones or antibodies used ...
... hospitals in Mumbai will soon start an integrated trauma ... and trauma care //to patients on way to a ... powerful American Association of Physicians of Indian Origin (AAPI), ... citizens to avail fully equipped ambulances within minutes of ...
... at the Johns Hopkins Urology Robotics Lab report the ... can safely power remote-controlled // robotic medical devices used ... imaging. The motor that drives the devices can be ... and more precise than a human hand. ,"Lots ...
... food industry is estimated to be worth over $200 million and ... Confederation of Indian Industry (CII). ,The growth of the ... the already booming food retail industry, which is currently growing at ... discussed in a two-day international food meet to be held in ...
Cached Medicine News:Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Many Women Undertreated for Ovarian Cancer 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 3Health News:Integrated Trauma Care Facility in Mumbai 2Health News:Integrated Trauma Care Facility in Mumbai 3Health News:MRI Robotic Biopsies Simplified by PneuStep 2
The CGRL is a Wide Angle Contact Glass designed for laser photocoagulation and diagnosis of the retina....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
... capture and management system that acquires extremely ... Angiography images. It interfaces with most current ... from any ophthalmic device with video, digital ... quality colour Retinal Images from non-mydriatic fundus ...
... device that replaces the old technology, the ... by bringing virtually unlimited charts to the ... are at the practitioners finger tips. The ... charts, optotypes, associated vision tests and fixation ...
Medicine Products: